Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
‘The Price of Business’: Discussing State Taxation of Student Loan Forgiveness

‘The Price of Business’: Discussing State Taxation of Student Loan Forgiveness

Oct 12, 2022 | Interviews

On October 12, Alex Brill joined Kevin Price on ‘The Price of Business’ to discuss the state tax implications of President Biden’s student loan relief plan. 

President Biden’s Student Loan Forgiveness: The Impact on Individuals’ State Taxes

President Biden’s Student Loan Forgiveness: The Impact on Individuals’ State Taxes

Sep 28, 2022 | Op-Eds

In a previous post, we explained how President Joe Biden’s student loan forgiveness plan could result in $4.8 billion in additional state income taxes from borrowers in seven states.

President Biden’s Student Loan Forgiveness: The Impact on State Tax Revenues

President Biden’s Student Loan Forgiveness: The Impact on State Tax Revenues

Sep 19, 2022 | Op-Eds

More than 43 million Americans will see their student loan debt partially or completely forgiven under President Biden’s student loan relief plan

  • Analysis (41)
  • Books (3)
  • Commentary (4)
  • Events (16)
  • Interviews (55)
  • News (54)
  • Op-Eds (82)
  • Press Releases (4)
  • Testimony (20)
  • PBMs in US Drug Pricing Debate
    MGA Releases White Paper on Role of PBMs in US Drug Pricing DebateSeptember 26, 2023
  • Unintended Consequences of Limiting PBMsSeptember 26, 2023
  • Importance of Prescription Drug Rebates
    ‘The Price of Business’: A Major Fiscal Crisis is Brewing and Largely Ignored by the MediaAugust 11, 2023
  • Congress takes on PBMs
    1 big thing: Congress takes on PBMsAugust 9, 2023
  • Here comes Humira competition
    Here comes Humira competition July 20, 2023
  • Humira Competitors Don’t Guarantee
    Humira Competitors Don’t Guarantee Lower Patient Drug CostsJuly 19, 2023
  • The State of Biosimilars
    The State of Biosimilars: What to WatchJuly 18, 2023
  • Importance of Prescription Drug Rebates
    ‘The Price of Business’: Discussing the Latest Inflation ReportJuly 12, 2023
  • Brill discusses adalimumab market
    Alex Brill Interviewed on the Future of the Adalimumab Market June 28, 2023
  • Unintended Consequences of Limiting PBMs
    Taking Stock of the Humira Biosimilars MarketJune 26, 2023
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact